HomepageMedicinePoseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos Medicine Poseida Therapeutics Enters into Partnership with Astellas Subsidiary Xyphos admin Posted on May 6, 2024 The two companies will work together to develop gene therapies in oncology. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostGodrej Properties Q4 net profit up 14% Next PostSustainability Activists Take Aim at Disposable Hotel Slippers You Might Also Like Medicine WHO Grants Prequalification to Typhoid Vaccine Developed by SK bioscience, International Vaccine Institute admin February 26, 2024 Medicine Amgen's Novel Weight Loss Drug Shows Potential for Longer Lasting Effect With Less Frequent Dosing Than Wegovy, Zepbound admin February 7, 2024 Medicine Navigating Distrust: Pharma in the Age of Social Media admin February 18, 2025 Medicine Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor admin July 25, 2024
Medicine WHO Grants Prequalification to Typhoid Vaccine Developed by SK bioscience, International Vaccine Institute admin February 26, 2024
Medicine Amgen's Novel Weight Loss Drug Shows Potential for Longer Lasting Effect With Less Frequent Dosing Than Wegovy, Zepbound admin February 7, 2024
Medicine Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor admin July 25, 2024